ABLYNX ANNOUNCES THAT SOFINNOVA SUCCESSFULLY COMPLETED PRIVATE PLACEMENT OF SHARES
(Thomson Reuters ONE) -
REGULATED INFORMATION
GHENT, Belgium, 18 November 2013 - Ablynx [Euronext Brussels: ABLX] has been
informed that Sofinnova Partners SAS has successfully completed a private
placement of its Ablynx shares through an accelerated bookbuilding procedure.
Sofinnova has placed 3,005,406 shares at ?7.26 per share (the last price on
18(th) November 2013 before the shares were suspended) with institutional
investors in both Europe and the United States. As a result, it now has sold its
complete stake in Ablynx.
Sofinnova Partners SAS is an independent venture capital firm based in Paris and
has been an investor in Ablynx since 2002.
KBC Securities NV and Kempen & Co N.V. acted on behalf of Sofinnova as joint
bookrunners for the placement.
About Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development
of Nanobodies®, a novel class of therapeutic proteins based on single-domain
antibody fragments, for a range of serious human diseases, including
inflammation, haematology, oncology and pulmonary disease. Today, the Company
has approximately 30 programmes in the pipeline and seven Nanobodies at clinical
development stage. Ablynx has on-going research collaborations and significant
partnerships with major pharmaceutical companies including AbbVie, Boehringer
Ingelheim, Eddingpharm, Merck & Co, Merck Serono and Novartis. The Company is
headquartered in Ghent, Belgium.
More information can be found on www.ablynx.com.
For more information, please contact
Ablynx:
Dr Edwin Moses
Chief Executive Officer
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
+32 (0)473 39 50 68
e: edwin.moses(at)ablynx.com
Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e: marieke.vermeersch(at)ablynx.com
Follow us on Twitter (at)AblynxABLX
Ablynx media relations Consilium Strategic Communications:
Mary-Jane Elliott, Amber Bielecka, Lindsey Neville
t: +44 207 920 2345
e: ablynx(at)consilium-comms.com
pdf version of the press release:
http://hugin.info/137912/R/1744039/586804.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ablynx via Thomson Reuters ONE
[HUG#1744039]
Unternehmensinformation / Kurzprofil:
Datum: 18.11.2013 - 19:24 Uhr
Sprache: Deutsch
News-ID 317781
Anzahl Zeichen: 3034
contact information:
Town:
Ghent/Zwijnaarde
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 228 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ABLYNX ANNOUNCES THAT SOFINNOVA SUCCESSFULLY COMPLETED PRIVATE PLACEMENT OF SHARES"
steht unter der journalistisch-redaktionellen Verantwortung von
Ablynx (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
